Source:http://linkedlifedata.com/resource/pubmed/id/18773185
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2008-11-26
|
pubmed:abstractText |
Podocytes are significant in establishing the glomerular filtration barrier. Sustained rennin-angiotensin system (RAS) activation is crucial in the pathogenesis of podocyte injury and causes proteinuria. This study demonstrates that angiotensin II (Ang II) caused a reactive oxygen species (ROS)-dependent rearrangement of cortical F-actin and a migratory phenotype switch in cultured mouse podocytes with stable Ang II type 1 receptor (AT1R) expression. Activated small GTPase Rac-1 and phosphorylated ezrin/radixin/moesin (ERM) proteins provoked Ang II-induced F-actin cytoskeletal remodeling. This work also shows increased expression of Rac-1 and phosphorylated ERM proteins in cultured podocytes, and in glomeruli of podocyte-specific AT1R transgenic rats (Neph-hAT1 TGRs). The free radical scavenger DMTU eliminated Ang II-induced cell migration, ERM protein phosphorylation and cortical F-actin remodeling, indicating that ROS mediates the influence of Rac-1 on podocyte AT1R signaling. Heparin, a potent G-coupled protein kinase 2 inhibitor, was found to abolish ERM protein phosphorylation and cortical F-actin ring formation in Ang II-treated podocytes, indicating that phosphorylated ERM proteins are the cytoskeletal effector in AT1R signaling. Moreover, Ang II stimulation triggered down-regulation of alpha actinin-4 and reduced focal adhesion expression in podocytes. Signaling inhibitor assay of Ang II-treated podocytes reveals that Rac-1, RhoA, and F-actin reorganization were involved in expressional regulation of alpha actinin-4 in AT1R signaling. With persistent RAS activation, the Ang II-induced phenotype shifts from being dynamically stable to adaptively migratory, which may eventually exhaust podocytes with a high actin cytoskeletal turnover, causing podocyte depletion and focal segmental glomerulosclerosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0946-2716
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1379-94
|
pubmed:dateRevised |
2011-7-8
|
pubmed:meshHeading |
pubmed-meshheading:18773185-Actins,
pubmed-meshheading:18773185-Angiotensin II,
pubmed-meshheading:18773185-Animals,
pubmed-meshheading:18773185-Cell Line,
pubmed-meshheading:18773185-Cell Movement,
pubmed-meshheading:18773185-Cell Shape,
pubmed-meshheading:18773185-Cytoskeleton,
pubmed-meshheading:18773185-Gene Expression Regulation,
pubmed-meshheading:18773185-Humans,
pubmed-meshheading:18773185-Mice,
pubmed-meshheading:18773185-Podocytes,
pubmed-meshheading:18773185-Rats,
pubmed-meshheading:18773185-Rats, Transgenic,
pubmed-meshheading:18773185-Reactive Oxygen Species,
pubmed-meshheading:18773185-Receptor, Angiotensin, Type 1
|
pubmed:year |
2008
|
pubmed:articleTitle |
Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.
|
pubmed:affiliation |
Department of Medicine D, Division of General Internal Medicine and Nephrology, University Hospital Muenster, Albert-Schweitzer-Str. 33, 48149 Muenster, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|